Breathtec Announces Name Change to Algernon Pharmaceuticals

UF startup Breathtec Biomedical Inc. is pleased to announce that as a result of the strength of the data from its Nash Pharmaceuticals pre-clinical research program, it will be changing its name to Algernon Pharmaceuticals Inc.

The change will take place before the market opens on February 19, and the Company’s ticker symbol will change from “BTH” to “AGN” on the Canadian Securities Exchange. Changes to the symbol for the Frankfurt and OTCQB exchanges are in progress and the Company will provide an update on the new symbols shortly. The Company’s new website will also be activated on February 19 and can be found at www.algernonpharmaceuticals.com.

Learn more about Breathtec Announces Name Change to Algernon Pharmaceuticals.